Related Experiment Video
Updated: Jul 15, 2026
06:46
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Colon cancer risk and different HRT formulations: a case-control study
Jürgen C Dinger1, Lothar A J Heinemann, Sabine Möhner
1Centre for Epidemiology & Health Research Berlin, Berlin, Germany. dinger@zeg-berlin.de <dinger@zeg-berlin.de>
BMC Cancer
|May 10, 2007
Summary
Hormone replacement therapy (HRT) use does not increase colon cancer risk. This study found no significant difference in colon cancer risk among various HRT formulations, suggesting a potentially reduced risk for HRT users.
Area of Science:
- Oncology
- Endocrinology
- Epidemiology
Background:
- Existing research indicates hormone replacement therapy (HRT) is not linked to increased colon cancer risk, with some studies even suggesting a decreased risk.
- However, data on the specific risks associated with different HRT preparations remains limited.
Purpose of the Study:
- To investigate the association between hormone replacement therapy (HRT) use and the risk of developing colon cancer.
- To explore potential differences in colon cancer risk related to various estrogen and progestin formulations used in HRT.
Main Methods:
- A case-control study was conducted in Germany, involving 354 colon cancer cases and 1422 matched controls.
- Conditional logistic regression was used to calculate odds ratios (OR) and 95% confidence intervals (95% CI), with stratified analyses for different HRT preparations.
Main Results:
- Overall HRT use was not associated with an increased risk of colon cancer (OR 0.97; 95% CI 0.71-1.32).
- No significant trends in colon cancer risk were observed with increasing duration or time since HRT use.
- While most HRT formulations showed a non-significantly reduced risk, differences between specific estrogen and progestin types, including conjugated equine estrogens (CEE) and medroxyprogesterone acetate (MPA), were not substantial.
Conclusions:
- Ever-use of HRT is not linked to an elevated risk of colon cancer.
- Findings suggest a potential non-significant reduction in colon cancer risk among HRT users, with no marked variation across different HRT formulations.
- Interpretation should be cautious due to small subgroup sample sizes and overlapping categories.
Related Concept Videos
01:12Hazard Ratio
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...
For example, in a clinical trial evaluating a...
02:59Cancer Prevention
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...